Investment projects
|
№ |
Title of the project |
Company |
Project Status |
|
1 |
Development of treatment methods for defects of ligaments, cartilage, neurological diseases by using autologous mesenchymal stem cells |
LLC"Trans-Technologies" |
initial research |
|
2 |
Development of hydrocolloids dressings containing antiseptics and healing wounds, for the treatment of infected wounds and nonhealing moisture ulcers |
LLC"Trans-Technologies" |
initial research |
|
3 |
Development of a method of restoring male reproductive function by autologous and allogenic cultures of stem and progenitor cells |
LLC"Trans-Technologies" |
initial research |
|
4 |
Development of model of myocardial infarction and cell therapy of cardiovascular diseases |
LLC"Trans-Technologies" |
initial research |
|
5 |
Development of a diagnostic kit "FarmakoGEN-SLC6A4" to determine the genetic risk of psycho-emotional instability |
LLC «VEGA» |
Completed |
|
6 |
Development of a diagnostic kit "TromboGEN-RT" to determine the risk of hereditary thrombophilia |
LLC «VEGA» |
Completed |
|
7 |
Development of a test system for the diagnosis of cystic fibrosis by analysis of mutations in the CFTR gene using DNA chip |
LLC «VEGA» |
Completed |
|
8 |
lDevelopment of a set of diagnostic kits "CardioGEN" for determining the risk of cardiovascular disease |
LLC «VEGA» |
Perspective project |
|
9 |
Preparation of a diagnostic kit "FarmakoGEN-Anticoagulants" for determining individual sensitivity to the indirect anticoagulants |
LLC «VEGA» |
Completed |
|
10 |
Development of methods for optimal development of physical qualities of an individual, depending on its genotype and the creation of a commercially available services in the form of specialized training programs tailored to the genetic characteristics of a human |
LLC «VEGA» |
Perspective project |
|
11 |
Development of a diagnostic kit for determining levels of protective antibodies against rubella virus in human blood and the establishment of a methodology for assessing the effectiveness of immunization on the basis of this set |
LLC «VEGA» |
Running |
|
12 |
Development of the skin test patch |
LLC «VEGA» |
Running |
|
13 |
Development of algorithm immunoassay and prevention of early atopic disease at the children |
LLC «VEGA» |
Running |
|
14 |
Development of ready-biotinylated forms of allergens |
LLC «VEGA» |
Running |
|
15 |
Development of ready-made forms of allergens for diagnosis (by scarification or skin prick test) |
LLC «VEGA» |
Running |
|
16 |
Development of a set for the determination of cortisol in human serum |
LLC «VEGA» |
Running |
|
17 |
Development of a set of reagents for immunoassay determination of 17-hydroxyprogesterone in serum and plasma (Steroid ELISA -17-OH-progesterone) |
LLC «VEGA» |
Completed |
|
18 |
Development of a set of reagents for immunoassay determination of estradiol in serum and blood plasma (Steroid ELISA -estradiol) |
LLC «VEGA» |
Completed |
|
19 |
Development of a set of reagents for immunoassay determination of free triiodothyronine in serum and plasma (Tiroid ELISA -free triiodothyronine) |
LLC «VEGA» |
Completed |
|
20 |
Development of a set of reagents for immunoassay to confirm the presence of HBV surface antigen in serum and blood plasma (Hepatitis ELISA -HBsAg) |
LLC «VEGA» |
Completed |
|
21 |
Development of a set of reagents for quantitative immunoassay for determination of surface antigen of HBV in serum and blood plasma (Hepatitis ELISA -HBsAg) |
LLC «VEGA» |
Completed |
|
22 |
Development of a set of reagents for the qualitative immunoassay detection of antibodies to HCV in serum and plasma of human blood (Hepatitis ELISA -anti-HCV) |
LLC «VEGA» |
Completed |
|
23 |
Development of a set of reagents for the qualitative enzyme immunoassay detection of antibodies and antigens of HIV in serum and plasma of human blood (HIV immunoassay -HIV-Ag/At) |
LLC «VEGA» |
Running |
|
24 |
Development of a set of reagents for the qualitative immunoassay detection of antibodies to HIV in serum and plasma of human blood (HIV immunoassay -anti-HIV-1, 2) |
LLC «VEGA» |
Completed |
|
25 |
Development of a set for the determination of progesterone in human serum |
LLC «VEGA» |
Running |
|
26 |
Development of enzyme immunoassay system for the quantitative determination of allergen-specific immunoglobulin E in human serum |
LLC «VEGA» |
Completed
|
|
27 |
Development of enzyme immunoassay system for determining the avidity of immunoglobulin G class to Toxoplasma gondii |
LLC «VEGA» |
Completed
|
|
28 |
Development of enzyme immunoassay system for qualitative and quantitative determination of immunoglobulin G to Toxoplasma gondii in human serum |
LLC «VEGA» |
Completed |
|
29 |
Development of a set for the determination of free β-subunit of HCG in human serum |
LLC «VEGA» |
Completed |
|
30 |
Development of enzyme immunoassay system for qualitative and quantitative determination of immunoglobulin G to Herpes simplex type 1 in human serum |
LLC «VEGA» |
Completed |
|
31 |
Development of enzyme immunoassay system for qualitative and quantitative determination of immunoglobulin G to Herpes simplex type 2 in human serum |
LLC «VEGA» |
Running |
|
32 |
Develop a set of definitions for PaPP-A in the blood serum of pregnant women |
LLC «VEGA» |
Completed |